1
			2									3
	4																											5
6																														7
																								8
												9
							10
			11																				12	13
																					14
			15																								16
17														18
					19		20																						21
				22
23													24
								25													26
											27							28
																						29
															30
					31
		32														33
										34

Across 2. are membrane stabilizing drugs and exert their actions on the sodium (fast) channels 3. mild symptoms of ________ include tinnitus, hearing loss, slight blurring of vision, and GI upset 6. the _____ _____ _____ of amiodarone is 10-150 days 8. with lidocaine, vials of ______ solution are labeled either for cardiac or not for cardiac use 9. ___________ is primarily indicated for the temporary control of a rapid ventricular response in patients with atrial fibrillation or flutter and PSVT 10. ________ can inhibit the metabolism of amiodarone, diopyramide and quinidine 11. ________ should be closely monitored when taking antidyrhythmics with warfarin 12. educate patients to limit or eliminate ________ 15. lidocaine's adverse effects include ____ _____ ____ 17. this drug is a class II (beta blocker) and used to treat both supraventricular and ventricular dysrhythmias (general myocardial depressent) 18. this drug is a class I a and is used for atrial fibrillation, premature atrial contractions, premature ventricular contractions, ventricular tachycardias and Wolff-Parkinson-White syndrome 20. works by blocking SNS stimulation to the heart 22. __________ interact with many different categories of drugs, the most serious are those that can result in dysrhythmias, hypo/hypertension, respiratory distress, or excessive therapeutic or toxic drug effects 23. any deviation from the normal rhythm of the heart 24. lidocaine can only be given by IV because it has extensive _____ _____ _____ 26. this drug is a class IV (calcium channel blockers) and used to treat paroxysmal supraventricular tachycardia, rate control for atrial fibrillation and flutter 29. with amiodarone, educate patient to immediately report any ______-_____ discoloration of the skin 30. this drug is a class I b and used to treat ventricular dysrhythmias only 31. Advise patients that the passage of the ____ _____ is normal and that the drug has been absorbed 32. are the calcium channel blockers 33. ________ can cause cinchonism 34. the ____ _____ of amiodarone is 15-100 days

Down 1. _________ is one of the most common adverse effects of amiodarone and may cause visual halos, photophobia and dry eyes 2. are the beta blockers 4. the most serious side effect of amiodarone and involves progressive dyspenia, and cough accompanied by damage to the alveoli 5. antidysrhythmics potentiate the anticoagulation effects of __________ 7. lidocaine labels should be ________ checked to be you have the correct concentration and form 13. this drug is a class III and used to treat life threatening ventricular tachycardia or fibrillation, 14. _____ _____ and other assessments related to the heart should be done before giving antidyrhythmics 16. _______ can cause hyperthyroidism or hypothyroidism 19. parenteral solutions of these drugs are usually stable only for ____ hours 21. many antidysrhythmics have an adverse effect of causing new ______ along with nausea, vomiting, diarrhea, dizziness, headache and blurred vision 23. this drug is also a class III and used to treat atrial fibrillation or flutter resistant to other drug therapy 24. this drug is a class I c and used to treat ventricular tachycardia and supraventricular tachycardia dysrhythmias, atrial fibrillation and flutter, and Wolff-Parkinson-White syndrome 25. increase the action potential duration by prolonging repolarization in phase 3 27. no rhythm or asystole 28. one of the most effective drugs for the treatment of ventricular dysrhythmias